Inhibition of Human B Cell Proliferation By Ion Channel Blockers

  • Bharathi Vayuvegula
  • Sastry Gollapudi
  • Sudhir Gupta
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 213)


Resting B cells can be activated by cross-linkage of their membrane immunoglobulins (Ig)(1–4). Anti-Ig antibodies, especially anti-IgM, causes resting B cells to enter and to progress through G1 phase of the cell cycle (5–6). B cells activated with anti-IgM antibody have shown to express Interleukin-2 receptors (IL-2R) and proliferate in response to exogenous IL-2 (7,8). Recently, calcium and calcium-activated K+ channels have been demonstrated in B cell hybridomas and B cell lymphoma lines (9–11). The role of these ion channels in B cell activation, proliferation and differentiation is however, not clearly understood. In this investigation, we have taken an indirect pharmacological approach to study a role of ion channels in anti-IgM-stimulated human B cell activation and proliferation.


Channel Blocker Thymidine Incorporation Cyanogen Bromide Peripheral Blood Mononuclear Cell Proliferation Membrane Immunoglobulin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Parker D.C. Stimulation of mouse lymphocytes by insoluble anti-mouse immunoglobulins. Nature 258:361, 1975ADSCrossRefGoogle Scholar
  2. 2.
    Weiner H.L., Moorehead J.W., and Claman H. Anti-immunoglobulin stimulation of murine lymphocytes. 1. Age dependency of the proliferative response. J. Immunol. 116:1656, 1976Google Scholar
  3. 3.
    Sieckman D.G., Asofsky G.R., Mosier D.E., Zitron I.M., and Paul W.E. Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response. J. Exp. Med. 147:814, 1978CrossRefGoogle Scholar
  4. 4.
    DeFranco A.L., Raveche E.S., Asofsky R., and Paul W.E. Frequency of B lymphocytes responsive to anti-immunoglobulin. J. Exp. Med. 155:1523, 1982CrossRefGoogle Scholar
  5. 5.
    Walker L., Guy G., Brown G., Rowe M., Milner A.E., and Gordon J. Control of human B-lymphocyte replication. 1. Characterization of novel activation states that precede the entry of G0 B cells into cycle. Immunology 58:583, 1986Google Scholar
  6. 6.
    Monroe J.G., and Kass M.J. Molecular events in B cell activation. I. Signals required to stimulate G0 to G1 transition of resting B lymphocytes. J. Immunol. 135:1674, 1985Google Scholar
  7. 7.
    Ando I., Crawford D.H., Kissonerghis M.A., Owen M.J. and Beverley P.C.L. Phorbol ester-induced expression and function of the interleukin 2 receptor in human B lymphocytes. Eur. J. Immunol. 15:341, 1985CrossRefGoogle Scholar
  8. 8.
    Emmrich F., Moll H., and Simon M.M. Recombinant human interleukin 2 acts as a B cell growth and differentiation promoting factor. Immunobiol. 169:97, 1985CrossRefGoogle Scholar
  9. 9.
    Fukushima Y., Hagiwara S. Voltage-gated Ca2+ channel in mouse myeloma cells. Proc. Natl. Acad. Sci. (USA). 80:2240, 1983ADSCrossRefGoogle Scholar
  10. 10.
    Fukushima Y. and Hagiwara S. Currents carried by monovalent cations through calcium channels in mouse neoplastic B lymphocytes. J. Physiol. 358:255, 1985Google Scholar
  11. 11.
    Pershadsingh H.A., Stubbs Jr. E.B., Noteboom W.D., Vorbeck M.L. and Martin A.P. Influence of Ca2+ on the plasma membrane potential and electrogenic uptake of glycine by myeloma cells. Involvement of a Ca2+-activated K+ channel. Biochem.Biophvs.Acta 821:445, 1985CrossRefGoogle Scholar
  12. 12.
    Ransom J.T. and Cambier J.C. B cell activation. VII. Independent and synergistic effects of mobilized calcium and diacylglycerol on membrane potential and I-A expression. J. Immunol. 136:66, 1986Google Scholar
  13. 13.
    Clevers H.C., Versteegen J.M.T., Logtenberg T., Gmelig-Meyling F.H.J. and Ballieux R.E. Synergistic action of A23187 and phorbol ester on human B cell activation. J. Immunol. 135: 3827, 1985Google Scholar
  14. 14.
    Neckers L.M., Yenokida G. and James S.P. The role of the transferrin receptor in human B lymphocyte activation. J. Immunol. 133:2437, 1984Google Scholar
  15. 15.
    Monroe J.G. and Cambier J.C. B cell activation. III. B cell plasma membrane depolarization and hyper-la antigen expression induced by receptor immunoglobulin cross-linking are coupled. J.Exp. Med. 158:1589, 1983CrossRefGoogle Scholar
  16. 16.
    Gollapudi S., Vayuvegula B., Chandy K.G., Thadepalli H. and Gupta S. Inhibition of anti-immunoglobulin-induced murine B lymphocyte proliferation by ion channel blockers. Fed. Proc. 44:974. 1985Google Scholar
  17. 17.
    Dugas B., Vazquez A., Delfraissy J-F., Gerard J-P., Rannou M-T, and Galanaud P. Human B cell activation: selective sensitivity of the early stages to calcium channel-blocking drugs. Eur. J. Immunol. 16:162, 1986CrossRefGoogle Scholar
  18. 18.
    Cahalan M.D., Chandy K.G., DeCoursey T.E. and Gupta S. A voltage-gated K+ channel in human T lymphocytes. J. Physiol. 358:197, 1985Google Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Bharathi Vayuvegula
    • 1
  • Sastry Gollapudi
    • 1
  • Sudhir Gupta
    • 1
  1. 1.Department of MedicineUniversity of CaliforniaIrvineUSA

Personalised recommendations